Hookipa Pharma Inc

+$0.72 (+4.28%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell HOOK and other stocks, options, and ETFs commission-free!

About HOOK

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its product includes VaxWace and TheraT.

CEO
Jörn Aldag
Employees
109
Headquarters
New York, New York
Founded
2011

HOOK Key Statistics

Market Cap
499.91M
Price-Earnings Ratio
Dividend Yield
Average Volume
253.70K
High Today
$18.07
Low Today
$16.56
Open Price
$17.00
Volume
404.93K
52 Week High
$18.09
52 Week Low
$8.10

HOOK News

BenzingaMay 12

Why HOOKIPA Pharma's Stock Is Trading Higher Today - Craft Brewers Alliance

HOOKIPA Pharma (NASDAQ:HOOK) shares are trading higher after the company reported better-than-expected Q1 sales results. HOOKIPA Pharma's stock is trading up 4
BenzingaMay 12

HOOKIPA Pharma: Q1 Earnings Insights

Shares of HOOKIPA Pharma (NASDAQ:HOOK) fell 6.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 23.26%

HOOK Earnings

-$0.65
-$0.53
-$0.40
-$0.28
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.53 per share
Actual
-$0.53 per share

You May Also Like

VERI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure